Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | MLH1 |
Variant | L155P |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | MLH1 L155P lies within the ATPase domain of the Mlh1 protein (PMID: 22753075). L155P has been identified in sequencing studies (PMID: 24686850), but has not been biochemically characterized and therefore, its effect on Mlh1 protein function is unknown (PubMed, Nov 2024). |
Associated Drug Resistance | |
Category Variants Paths |
MLH1 mutant MLH1 L155P |
Transcript | NM_000249.4 |
gDNA | chr3:g.37008824T>C |
cDNA | c.464T>C |
Protein | p.L155P |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_005265161.2 | chr3:g.37008824T>C | c.464T>C | p.L155P | RefSeq | GRCh38/hg38 |
XM_005265161 | chr3:g.37008824T>C | c.464T>C | p.L155P | RefSeq | GRCh38/hg38 |
NM_001354628.1 | chr3:g.37008824T>C | c.464T>C | p.L155P | RefSeq | GRCh38/hg38 |
NM_001354628.2 | chr3:g.37008824T>C | c.464T>C | p.L155P | RefSeq | GRCh38/hg38 |
NM_001258271.2 | chr3:g.37008824T>C | c.464T>C | p.L155P | RefSeq | GRCh38/hg38 |
NM_001354630.1 | chr3:g.37008824T>C | c.464T>C | p.L155P | RefSeq | GRCh38/hg38 |
NM_000249.4 | chr3:g.37008824T>C | c.464T>C | p.L155P | RefSeq | GRCh38/hg38 |
NM_000249.3 | chr3:g.37008824T>C | c.464T>C | p.L155P | RefSeq | GRCh38/hg38 |
XM_005265161.3 | chr3:g.37008824T>C | c.464T>C | p.L155P | RefSeq | GRCh38/hg38 |
NM_000249 | chr3:g.37008824T>C | c.464T>C | p.L155P | RefSeq | GRCh38/hg38 |
NM_001258271 | chr3:g.37008824T>C | c.464T>C | p.L155P | RefSeq | GRCh38/hg38 |
NM_001354630.2 | chr3:g.37008824T>C | c.464T>C | p.L155P | RefSeq | GRCh38/hg38 |
NM_001258271.1 | chr3:g.37008824T>C | c.464T>C | p.L155P | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|